U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
SEC FILE NUMBER
0-9922
CUSIP NUMBER
(Check One): 025569
[ ]Form 10-K and Form 10-KSB [ ]Form 20-F
[ ] Form 11-K [X]Form 10-Q and Form 10-QSB [ ]Form N-SAR
For Period Ended: April 25, 1997
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
-------------------------------------------------------------------------
Read Attached Instruction Sheet Before Preparing Form. Please Print or
Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
-------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates: Not Applicable.
------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
-------------------------------------------------------------------------
Full Name of Registrant: American Electromedics Corp.
----------------------------
Former Name If Applicable: N/A
-----------------------------
13 Columbia Drive, Suite 18, Amherst, New Hampshire 03031
-----------------------------------------------------------
Address of Principal Executive Office
(Street and Number), City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
-------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
[x] (a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable effort
or expense;
[x] (b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or
portion thereof will be filed on or before the fifteenth
calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q,
or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
<PAGE>
-------------------------------------------------------------------------
PART III - NARRATIVE
-------------------------------------------------------------------------
State below in reasonable detail the reasons why Form 10-K and 10-KSB,
20-F, 11-K, 10-Q and 10-QSB, N-SAR, or the transition report or portion
thereof could not be filed within the prescribed period.
(Attach Extra Sheets if Needed)
Registrant experienced delays in compiling the necessary information
to complete the report.
-------------------------------------------------------------------------
PART IV - OTHER INFORMATION
-------------------------------------------------------------------------
(1) Name and telephone number of person to contact in regard to this
notification
Michael T. Pieniazek (603) 880-6300
-------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13
or 15(d) of the Securities Exchange Act of 1934 or section
30 of the Investment Company Act of 1940 during the preceding
12 months or for such shorter period that the registrant
was required to file such report(s) been filed? If answer
is no, identify report(s).
[X]Yes [ ]No
______________________________________________________________________
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal
year will be reflected by the earnings statements to be
included in the subject report or portion thereof?
[X]Yes [ ]No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
American Electromedics Corp.
------------------------------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: June 10, 1997 By: /s/ Michael T. Pieniazek
------------------ ------------------------------------
Name: Michael T. Pieniazek
Title: Chief Financial Officer
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and
title of the person signing the form shall be typed or printed beneath
the signature. If the statement is signed on behalf of the registrant by
an authorized representative (other than an executive officer), evidence
of the representative's authority to sign on behalf of the registrant
shall be filed with the form.
-------------------------------------------------------------------------
ATTENTION
-------------------------------------------------------------------------
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C.) 1001).
<PAGE>
AMERICAN ELECTROMEDICS CORP.
Attachment to Form 12b-25
Part IV(3)- For the third quarter of fiscal 1997 the Registrant
experienced a signficant decrease in sales and an increase in general and
adminstrative expenses along with valuation adjustments for certain of
the Registrant's assets as compared with the corresponding quarter in
fiscal 1996.
The Registrant expects to report a net loss of from $300,000 to
$500,000 for the third quarter of fiscal 1997 as compared with net income
of approximately $200,000 for the corresponding quarter in fiscal 1996.
